HEADER HYDROLASE 30-SEP-12 4BBZ TITLE STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY CBDP (2-MIN TITLE 2 SOAK): CRESYL-PHOSPHOSERINE ADDUCT COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHOLINESTERASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 29-557; COMPND 5 SYNONYM: ACYLCHOLINE ACYLHYDROLASE, BUTYRYLCHOLINE ESTERASE, CHOLINE COMPND 6 ESTERASE II, PSEUDOCHOLINESTERASE; COMPND 7 EC: 3.1.1.8; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 OTHER_DETAILS: CRESYL-PHOSPHATE ADDUCT ON S198 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: CHO-K1; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGS KEYWDS HYDROLASE, ACETYLCHOLINESTERASE, NERVE TRANSMISSION, INHIBITION, KEYWDS 2 ALPHA-BETA HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR E.CARLETTI,J.-P.COLLETIER,L.M.SCHOPFER,G.SANTONI,P.MASSON, AUTHOR 2 O.LOCKRIDGE,F.NACHON,M.WEIK REVDAT 4 20-DEC-23 4BBZ 1 REMARK HETSYN REVDAT 3 29-JUL-20 4BBZ 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE ATOM REVDAT 2 06-MAR-13 4BBZ 1 JRNL REVDAT 1 06-FEB-13 4BBZ 0 JRNL AUTH E.CARLETTI,J.-P.COLLETIER,L.M.SCHOPFER,G.SANTONI,P.MASSON, JRNL AUTH 2 O.LOCKRIDGE,F.NACHON,M.WEIK JRNL TITL INHIBITION PATHWAYS OF THE POTENT ORGANOPHOSPHATE CBDP WITH JRNL TITL 2 CHOLINESTERASES REVEALED BY X-RAY CRYSTALLOGRAPHIC SNAPSHOTS JRNL TITL 3 AND MASS SPECTROMETRY JRNL REF CHEM.RES.TOXICOL. V. 26 280 2013 JRNL REFN ISSN 0893-228X JRNL PMID 23339663 JRNL DOI 10.1021/TX3004505 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.1_1168) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 54.69 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 21049 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.166 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1053 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 54.6988 - 5.3987 0.96 2602 137 0.1815 0.2212 REMARK 3 2 5.3987 - 4.2856 0.98 2510 133 0.1454 0.1948 REMARK 3 3 4.2856 - 3.7440 0.98 2503 131 0.1430 0.2186 REMARK 3 4 3.7440 - 3.4018 0.98 2475 130 0.1545 0.2021 REMARK 3 5 3.4018 - 3.1580 0.99 2464 130 0.1768 0.2329 REMARK 3 6 3.1580 - 2.9718 0.99 2495 131 0.1853 0.2914 REMARK 3 7 2.9718 - 2.8230 0.99 2477 131 0.1983 0.2715 REMARK 3 8 2.8230 - 2.7001 0.99 2470 130 0.2015 0.2752 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.190 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4534 REMARK 3 ANGLE : 1.269 6176 REMARK 3 CHIRALITY : 0.088 674 REMARK 3 PLANARITY : 0.004 775 REMARK 3 DIHEDRAL : 19.883 1681 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A AND (RESSEQ 3:316) REMARK 3 ORIGIN FOR THE GROUP (A): -14.7815 -32.1307 -35.3739 REMARK 3 T TENSOR REMARK 3 T11: 0.2526 T22: 0.1341 REMARK 3 T33: 0.1826 T12: -0.0817 REMARK 3 T13: -0.0397 T23: -0.1293 REMARK 3 L TENSOR REMARK 3 L11: 1.7111 L22: 1.6131 REMARK 3 L33: 2.5274 L12: 0.4409 REMARK 3 L13: 0.1482 L23: 0.4177 REMARK 3 S TENSOR REMARK 3 S11: -0.0536 S12: 0.3157 S13: -0.2752 REMARK 3 S21: -0.4094 S22: 0.1311 S23: -0.0890 REMARK 3 S31: 0.1528 S32: 0.0362 S33: 0.0492 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN A AND (RESSEQ 317:529) REMARK 3 ORIGIN FOR THE GROUP (A): -19.4174 -31.9835 -10.8545 REMARK 3 T TENSOR REMARK 3 T11: 0.1418 T22: 0.1915 REMARK 3 T33: 0.1819 T12: -0.0458 REMARK 3 T13: -0.0752 T23: -0.0754 REMARK 3 L TENSOR REMARK 3 L11: 1.2429 L22: 2.1013 REMARK 3 L33: 2.2652 L12: 0.0125 REMARK 3 L13: 0.4689 L23: -0.2786 REMARK 3 S TENSOR REMARK 3 S11: 0.0000 S12: -0.4443 S13: -0.1678 REMARK 3 S21: 0.1672 S22: 0.1314 S23: 0.0708 REMARK 3 S31: 0.1157 S32: -0.3262 S33: 0.0746 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4BBZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-SEP-12. REMARK 100 THE DEPOSITION ID IS D_1290054212. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9765 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21049 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 54.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 10.10 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 29.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 9.20 REMARK 200 R MERGE FOR SHELL (I) : 0.46000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1P0I REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM 2.1 M REMARK 280 AMMONIUM SULFATE, 0.1 M MES BUFFER PH 6.5. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 4 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 9555 X+1/2,Y+1/2,Z+1/2 REMARK 290 10555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 11555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 12555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 13555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 14555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 15555 Y+1/2,X+1/2,-Z+1/2 REMARK 290 16555 -Y+1/2,-X+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 1.000000 0.000000 0.000000 77.34000 REMARK 290 SMTRY2 9 0.000000 1.000000 0.000000 77.34000 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 63.49500 REMARK 290 SMTRY1 10 -1.000000 0.000000 0.000000 77.34000 REMARK 290 SMTRY2 10 0.000000 -1.000000 0.000000 77.34000 REMARK 290 SMTRY3 10 0.000000 0.000000 1.000000 63.49500 REMARK 290 SMTRY1 11 0.000000 -1.000000 0.000000 77.34000 REMARK 290 SMTRY2 11 1.000000 0.000000 0.000000 77.34000 REMARK 290 SMTRY3 11 0.000000 0.000000 1.000000 63.49500 REMARK 290 SMTRY1 12 0.000000 1.000000 0.000000 77.34000 REMARK 290 SMTRY2 12 -1.000000 0.000000 0.000000 77.34000 REMARK 290 SMTRY3 12 0.000000 0.000000 1.000000 63.49500 REMARK 290 SMTRY1 13 -1.000000 0.000000 0.000000 77.34000 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 77.34000 REMARK 290 SMTRY3 13 0.000000 0.000000 -1.000000 63.49500 REMARK 290 SMTRY1 14 1.000000 0.000000 0.000000 77.34000 REMARK 290 SMTRY2 14 0.000000 -1.000000 0.000000 77.34000 REMARK 290 SMTRY3 14 0.000000 0.000000 -1.000000 63.49500 REMARK 290 SMTRY1 15 0.000000 1.000000 0.000000 77.34000 REMARK 290 SMTRY2 15 1.000000 0.000000 0.000000 77.34000 REMARK 290 SMTRY3 15 0.000000 0.000000 -1.000000 63.49500 REMARK 290 SMTRY1 16 0.000000 -1.000000 0.000000 77.34000 REMARK 290 SMTRY2 16 -1.000000 0.000000 0.000000 77.34000 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 63.49500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 1 REMARK 465 ASP A 2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 40 CD REMARK 480 GLU A 432 CD REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 485 C1 NAG A 580 1.44 REMARK 500 ND2 ASN A 57 C1 NAG B 1 1.44 REMARK 500 ND2 ASN A 341 C1 NAG D 1 1.44 REMARK 500 ND2 ASN A 241 C1 NAG C 1 1.46 REMARK 500 UNK UNX A 706 UNK UNX A 709 1.83 REMARK 500 UNK UNX A 709 UNK UNX A 710 1.90 REMARK 500 UNK UNX A 707 UNK UNX A 709 2.00 REMARK 500 UNK UNX A 707 UNK UNX A 710 2.10 REMARK 500 O HOH A 2072 O HOH A 2090 2.11 REMARK 500 O HOH A 2071 O HOH A 2090 2.15 REMARK 500 ND2 ASN A 485 C2 NAG A 580 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NH2 ARG A 509 O2 SO4 A 703 7555 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER A 198 CA SER A 198 CB 0.123 REMARK 500 SER A 198 CB SER A 198 OG 0.257 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER A 198 CA - CB - OG ANGL. DEV. = 16.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 43 -8.00 70.66 REMARK 500 LYS A 45 157.47 -48.01 REMARK 500 ASP A 54 -170.66 60.17 REMARK 500 ASP A 87 134.88 -37.44 REMARK 500 SER A 89 149.52 -173.49 REMARK 500 LYS A 103 120.79 -34.63 REMARK 500 ASN A 106 59.73 -144.99 REMARK 500 ASN A 159 109.35 -48.10 REMARK 500 ALA A 162 75.11 -161.37 REMARK 500 SER A 198 -123.45 59.38 REMARK 500 ASP A 297 -77.19 -136.33 REMARK 500 ASP A 378 84.20 62.48 REMARK 500 ASP A 379 -59.26 -138.42 REMARK 500 PHE A 398 -62.93 -136.97 REMARK 500 PRO A 480 48.97 -83.83 REMARK 500 ASN A 485 62.71 -116.56 REMARK 500 ASN A 486 46.83 39.62 REMARK 500 THR A 496 -58.61 72.34 REMARK 500 GLU A 506 -73.23 -93.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG B 1 REMARK 610 NAG C 1 REMARK 610 NAG D 1 REMARK 610 NAG A 580 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1EHO RELATED DB: PDB REMARK 900 MODEL OF (-)-COCAINE-BOUND BCHE COMPLEX. REMARK 900 RELATED ID: 1EHQ RELATED DB: PDB REMARK 900 MODEL OF (+)-COCAINE-BOUND BCHE COMPLEX REMARK 900 RELATED ID: 1KCJ RELATED DB: PDB REMARK 900 MODEL OF (-)-COCAINE-BOUND (-)-COCAINE HYDROLASE COMPLEX REMARK 900 RELATED ID: 1P0I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE REMARK 900 RELATED ID: 1P0M RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE INCOMPLEX WITH A REMARK 900 CHOLINE MOLECULE REMARK 900 RELATED ID: 1P0P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN REMARK 900 COMPLEX WITH THE SUBSTRATE ANALOGBUTYRYLTHIOCHOLINE REMARK 900 RELATED ID: 1P0Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYL CHOLINESTERASE REMARK 900 RELATED ID: 1XLU RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF DI-ISOPROPYL-PHOSPHORO-FLUORIDATE ( DFP) REMARK 900 INHIBITED BUTYRYLCHOLINESTERASE AFTER AGING REMARK 900 RELATED ID: 1XLV RELATED DB: PDB REMARK 900 ETHYLPHOSPHORYLATED BUTYRYLCHOLINESTERASE (AGED) OBTAINEDBY REMARK 900 REACTION WITH ECHOTHIOPHATE REMARK 900 RELATED ID: 1XLW RELATED DB: PDB REMARK 900 DIETHYLPHOSPHORYLATED BUTYRYLCHOLINESTERASE (NONAGED)OBTAINED BY REMARK 900 REACTION WITH ECHOTHIOPHATE REMARK 900 RELATED ID: 2J4C RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 10MM HGCL2 REMARK 900 RELATED ID: 2WID RELATED DB: PDB REMARK 900 AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN REMARK 900 ANALOGUE TA1 REMARK 900 RELATED ID: 2WIF RELATED DB: PDB REMARK 900 AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN REMARK 900 ANALOGUE TA1 REMARK 900 RELATED ID: 2WIG RELATED DB: PDB REMARK 900 NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN REMARK 900 ANALOGUE TA4 REMARK 900 RELATED ID: 2WIJ RELATED DB: PDB REMARK 900 NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN REMARK 900 ANALOGUE TA5 REMARK 900 RELATED ID: 2WIK RELATED DB: PDB REMARK 900 NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN REMARK 900 ANALOGUE TA6 REMARK 900 RELATED ID: 2WIL RELATED DB: PDB REMARK 900 AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN REMARK 900 ANALOGUE TA5 REMARK 900 RELATED ID: 2WSL RELATED DB: PDB REMARK 900 AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN REMARK 900 ANALOGUE TA4 REMARK 900 RELATED ID: 2XMB RELATED DB: PDB REMARK 900 G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH SULFATE REMARK 900 RELATED ID: 2XMC RELATED DB: PDB REMARK 900 G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH REMARK 900 FLUORIDE ANION REMARK 900 RELATED ID: 2XMD RELATED DB: PDB REMARK 900 G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH REMARK 900 ECHOTHIOPHATE REMARK 900 RELATED ID: 2XMG RELATED DB: PDB REMARK 900 G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH VX REMARK 900 RELATED ID: 2XQF RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC REMARK 900 VX REMARK 900 RELATED ID: 2XQG RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC REMARK 900 VR REMARK 900 RELATED ID: 2XQI RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC REMARK 900 CVX REMARK 900 RELATED ID: 2XQJ RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY PURE REMARK 900 ENANTIOMER VX-(R) REMARK 900 RELATED ID: 2XQK RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY PURE REMARK 900 ENANTIOMER VX-(S) REMARK 900 RELATED ID: 2Y1K RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY CBDP (12H REMARK 900 SOAK): PHOSPHOSERINE ADDUCT REMARK 900 RELATED ID: 4AQD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HUMAN BUTYRYLCHOLINESTERASE REMARK 900 RELATED ID: 4AXB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN REMARK 900 COMPLEX WITH 2-PAM REMARK 900 RELATED ID: 4B0O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN REMARK 900 COMPLEX WITH BENZYL PYRIDINIUM-4 -METHYLTRICHLOROACETIMIDATE REMARK 900 RELATED ID: 4B0P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN REMARK 900 COMPLEX WITH METHYL 2-( PENTAFLUOROBENZYLOXYIMINO)PYRIDINIUM REMARK 900 RELATED ID: 4BC0 RELATED DB: PDB REMARK 900 STRUCTURE OF MOUSE ACETYLCHOLINESTERASE INHIBITED BY CBDP (12-H REMARK 900 SOAK): CRESYL-PHOSPHOSERINE ADDUCT REMARK 900 RELATED ID: 4BC1 RELATED DB: PDB REMARK 900 STRUCTURE OF MOUSE ACETYLCHOLINESTERASE INHIBITED BY CBDP (30-MIN REMARK 900 SOAK): CRESYL-SALIGENIN-PHOSPHOSERINE ADDUCT DBREF 4BBZ A 1 529 UNP P06276 CHLE_HUMAN 29 557 SEQADV 4BBZ GLN A 17 UNP P06276 ASN 45 ENGINEERED MUTATION SEQADV 4BBZ GLN A 455 UNP P06276 ASN 483 ENGINEERED MUTATION SEQADV 4BBZ GLN A 481 UNP P06276 ASN 509 ENGINEERED MUTATION SEQRES 1 A 529 GLU ASP ASP ILE ILE ILE ALA THR LYS ASN GLY LYS VAL SEQRES 2 A 529 ARG GLY MET GLN LEU THR VAL PHE GLY GLY THR VAL THR SEQRES 3 A 529 ALA PHE LEU GLY ILE PRO TYR ALA GLN PRO PRO LEU GLY SEQRES 4 A 529 ARG LEU ARG PHE LYS LYS PRO GLN SER LEU THR LYS TRP SEQRES 5 A 529 SER ASP ILE TRP ASN ALA THR LYS TYR ALA ASN SER CYS SEQRES 6 A 529 CYS GLN ASN ILE ASP GLN SER PHE PRO GLY PHE HIS GLY SEQRES 7 A 529 SER GLU MET TRP ASN PRO ASN THR ASP LEU SER GLU ASP SEQRES 8 A 529 CYS LEU TYR LEU ASN VAL TRP ILE PRO ALA PRO LYS PRO SEQRES 9 A 529 LYS ASN ALA THR VAL LEU ILE TRP ILE TYR GLY GLY GLY SEQRES 10 A 529 PHE GLN THR GLY THR SER SER LEU HIS VAL TYR ASP GLY SEQRES 11 A 529 LYS PHE LEU ALA ARG VAL GLU ARG VAL ILE VAL VAL SER SEQRES 12 A 529 MET ASN TYR ARG VAL GLY ALA LEU GLY PHE LEU ALA LEU SEQRES 13 A 529 PRO GLY ASN PRO GLU ALA PRO GLY ASN MET GLY LEU PHE SEQRES 14 A 529 ASP GLN GLN LEU ALA LEU GLN TRP VAL GLN LYS ASN ILE SEQRES 15 A 529 ALA ALA PHE GLY GLY ASN PRO LYS SER VAL THR LEU PHE SEQRES 16 A 529 GLY GLU SER ALA GLY ALA ALA SER VAL SER LEU HIS LEU SEQRES 17 A 529 LEU SER PRO GLY SER HIS SER LEU PHE THR ARG ALA ILE SEQRES 18 A 529 LEU GLN SER GLY SER PHE ASN ALA PRO TRP ALA VAL THR SEQRES 19 A 529 SER LEU TYR GLU ALA ARG ASN ARG THR LEU ASN LEU ALA SEQRES 20 A 529 LYS LEU THR GLY CYS SER ARG GLU ASN GLU THR GLU ILE SEQRES 21 A 529 ILE LYS CYS LEU ARG ASN LYS ASP PRO GLN GLU ILE LEU SEQRES 22 A 529 LEU ASN GLU ALA PHE VAL VAL PRO TYR GLY THR PRO LEU SEQRES 23 A 529 SER VAL ASN PHE GLY PRO THR VAL ASP GLY ASP PHE LEU SEQRES 24 A 529 THR ASP MET PRO ASP ILE LEU LEU GLU LEU GLY GLN PHE SEQRES 25 A 529 LYS LYS THR GLN ILE LEU VAL GLY VAL ASN LYS ASP GLU SEQRES 26 A 529 GLY THR ALA PHE LEU VAL TYR GLY ALA PRO GLY PHE SER SEQRES 27 A 529 LYS ASP ASN ASN SER ILE ILE THR ARG LYS GLU PHE GLN SEQRES 28 A 529 GLU GLY LEU LYS ILE PHE PHE PRO GLY VAL SER GLU PHE SEQRES 29 A 529 GLY LYS GLU SER ILE LEU PHE HIS TYR THR ASP TRP VAL SEQRES 30 A 529 ASP ASP GLN ARG PRO GLU ASN TYR ARG GLU ALA LEU GLY SEQRES 31 A 529 ASP VAL VAL GLY ASP TYR ASN PHE ILE CYS PRO ALA LEU SEQRES 32 A 529 GLU PHE THR LYS LYS PHE SER GLU TRP GLY ASN ASN ALA SEQRES 33 A 529 PHE PHE TYR TYR PHE GLU HIS ARG SER SER LYS LEU PRO SEQRES 34 A 529 TRP PRO GLU TRP MET GLY VAL MET HIS GLY TYR GLU ILE SEQRES 35 A 529 GLU PHE VAL PHE GLY LEU PRO LEU GLU ARG ARG ASP GLN SEQRES 36 A 529 TYR THR LYS ALA GLU GLU ILE LEU SER ARG SER ILE VAL SEQRES 37 A 529 LYS ARG TRP ALA ASN PHE ALA LYS TYR GLY ASN PRO GLN SEQRES 38 A 529 GLU THR GLN ASN ASN SER THR SER TRP PRO VAL PHE LYS SEQRES 39 A 529 SER THR GLU GLN LYS TYR LEU THR LEU ASN THR GLU SER SEQRES 40 A 529 THR ARG ILE MET THR LYS LEU ARG ALA GLN GLN CYS ARG SEQRES 41 A 529 PHE TRP THR SER PHE PHE PRO LYS VAL MODRES 4BBZ ASN A 106 ASN GLYCOSYLATION SITE MODRES 4BBZ ASN A 256 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET FUL B 2 10 HET NAG C 1 14 HET NAG C 2 14 HET FUL C 3 10 HET NAG D 1 14 HET NAG D 2 14 HET FUL D 3 10 HET UNX A 705 1 HET UNX A 706 1 HET UNX A 707 1 HET UNX A 709 1 HET UNX A 710 1 HET UNX A 711 1 HET UNX A 712 1 HET NAG A 550 14 HET NAG A 580 14 HET NAG A 590 14 HET SO4 A 700 5 HET SO4 A 701 5 HET SO4 A 702 5 HET SO4 A 703 5 HET SO4 A 704 5 HET CL A 713 1 HET 4OJ A1530 11 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUL BETA-L-FUCOPYRANOSE HETNAM UNX UNKNOWN ATOM OR ION HETNAM SO4 SULFATE ION HETNAM CL CHLORIDE ION HETNAM 4OJ (2-METHYLPHENYL) DIHYDROGEN PHOSPHATE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUL BETA-L-FUCOSE; 6-DEOXY-BETA-L-GALACTOPYRANOSE; L- HETSYN 2 FUL FUCOSE; FUCOSE; 6-DEOXY-BETA-L-GALACTOSE HETSYN 4OJ O-CRESYL-PHOSPHATE FORMUL 2 NAG 8(C8 H15 N O6) FORMUL 2 FUL 3(C6 H12 O5) FORMUL 5 UNX 7(X) FORMUL 15 SO4 5(O4 S 2-) FORMUL 20 CL CL 1- FORMUL 21 4OJ C7 H9 O4 P FORMUL 22 HOH *139(H2 O) HELIX 1 1 LEU A 38 ARG A 42 5 5 HELIX 2 2 PHE A 76 MET A 81 1 6 HELIX 3 3 LEU A 125 ASP A 129 5 5 HELIX 4 4 GLY A 130 ARG A 138 1 9 HELIX 5 5 GLY A 149 LEU A 154 1 6 HELIX 6 6 ASN A 165 ILE A 182 1 18 HELIX 7 7 ALA A 183 PHE A 185 5 3 HELIX 8 8 SER A 198 SER A 210 1 13 HELIX 9 9 PRO A 211 PHE A 217 5 7 HELIX 10 10 SER A 235 THR A 250 1 16 HELIX 11 11 ASN A 256 ASN A 266 1 11 HELIX 12 12 ASP A 268 GLU A 276 1 9 HELIX 13 13 ALA A 277 VAL A 279 5 3 HELIX 14 14 MET A 302 LEU A 309 1 8 HELIX 15 15 GLY A 326 VAL A 331 1 6 HELIX 16 16 THR A 346 PHE A 358 1 13 HELIX 17 17 SER A 362 THR A 374 1 13 HELIX 18 18 GLU A 383 PHE A 398 1 16 HELIX 19 19 PHE A 398 GLU A 411 1 14 HELIX 20 20 PRO A 431 GLY A 435 5 5 HELIX 21 21 GLU A 441 PHE A 446 1 6 HELIX 22 22 GLY A 447 GLU A 451 5 5 HELIX 23 23 THR A 457 GLY A 478 1 22 HELIX 24 24 ARG A 515 PHE A 525 1 11 HELIX 25 25 PHE A 526 VAL A 529 5 4 SHEET 1 AA 3 ILE A 5 THR A 8 0 SHEET 2 AA 3 GLY A 11 ARG A 14 -1 O GLY A 11 N THR A 8 SHEET 3 AA 3 ILE A 55 ASN A 57 1 O TRP A 56 N ARG A 14 SHEET 1 AB11 MET A 16 VAL A 20 0 SHEET 2 AB11 GLY A 23 PRO A 32 -1 O GLY A 23 N VAL A 20 SHEET 3 AB11 TYR A 94 PRO A 100 -1 O LEU A 95 N ILE A 31 SHEET 4 AB11 ILE A 140 MET A 144 -1 O VAL A 141 N TRP A 98 SHEET 5 AB11 ALA A 107 ILE A 113 1 O THR A 108 N ILE A 140 SHEET 6 AB11 GLY A 187 GLU A 197 1 N ASN A 188 O ALA A 107 SHEET 7 AB11 ARG A 219 GLN A 223 1 O ARG A 219 N LEU A 194 SHEET 8 AB11 ILE A 317 ASN A 322 1 O LEU A 318 N LEU A 222 SHEET 9 AB11 ALA A 416 PHE A 421 1 O PHE A 417 N VAL A 319 SHEET 10 AB11 LYS A 499 LEU A 503 1 O LEU A 501 N TYR A 420 SHEET 11 AB11 ILE A 510 THR A 512 -1 O MET A 511 N TYR A 500 SHEET 1 AC 2 SER A 64 CYS A 65 0 SHEET 2 AC 2 LEU A 88 SER A 89 1 N SER A 89 O SER A 64 SSBOND 1 CYS A 65 CYS A 92 1555 1555 2.04 SSBOND 2 CYS A 252 CYS A 263 1555 1555 2.04 SSBOND 3 CYS A 400 CYS A 519 1555 1555 2.04 LINK ND2 ASN A 106 C1 NAG A 550 1555 1555 1.46 LINK OG SER A 198 P13 4OJ A1530 1555 1555 2.02 LINK ND2 ASN A 256 C1 NAG A 590 1555 1555 1.44 LINK O6 NAG B 1 C1 FUL B 2 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.46 LINK O6 NAG C 1 C1 FUL C 3 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.45 LINK O6 NAG D 1 C1 FUL D 3 1555 1555 1.45 CISPEP 1 ALA A 101 PRO A 102 0 2.82 CISPEP 2 ASP A 378 ASP A 379 0 -16.83 CISPEP 3 ASP A 379 GLN A 380 0 -3.81 CRYST1 154.680 154.680 126.990 90.00 90.00 90.00 I 4 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006465 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006465 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007875 0.00000